Neurofilament Light Biomarkers Identify Alzheimer Disease Risk in Down Syndrome

Investigators analyzed the diagnostic performance of plasma cerebrospinal fluid and neurofilament light biomarkers in patients with Down syndrome and Alzheimer disease.

Source link

Related posts

Editors' note: Increasing prevalence of vascular risk factors in patients with stroke: A call to action


Human Motor Thalamus Reconstructed in 3D from Continuous Sagittal Sections with Identified Subcortical Afferent Territories.


Top Tips for Attaining Work-Life Balance for Parents of High Needs Children


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy